Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-07-000060
Filing Date
2007-11-14
Accepted
2007-11-14 16:15:49
Documents
7
Period of Report
2007-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10QSB a2007_40-10q.htm 10-Q 455694
2 AMENDMENT TO ORACLE & AFFILIATES CONVERTIBLE NOTES ex_10-43.htm EX-10.43 23162
3 AMENDMENT TO SCO & AFFILIATES CONVERTIBLE NOTES ex_10-44.htm EX-10.44 110059
4 CERTIFICATION CEO ex_31-1.htm EX-31.1 17586
5 CERTIFICATION CFO ex_31-2.htm EX-31.2 17951
6 CERTIFICATION CEO ex_32-1.htm EX-32.1 6409
7 CERTIFICATION CFO ex_32-2.htm EX-32.2 5892
  Complete submission text file 0000318306-07-000060.txt   638374
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 071245046
SIC: 2834 Pharmaceutical Preparations